| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 12, 2019 | 0.00 | 0.00 | 226.00 | 237.50 | 154,709 |
| Jul 11, 2019 | 271.25 | 271.25 | 240.00 | 242.50 | 294,391 |
| Jul 10, 2019 | 260.00 | 279.00 | 256.00 | 275.00 | 224,102 |
| Jul 9, 2019 | 244.00 | 260.00 | 240.51 | 255.00 | 212,143 |
| Jul 8, 2019 | 229.00 | 248.90 | 222.61 | 240.00 | 120,151 |
| Name | ReNeuron Group | Epic | RENE |
|---|---|---|---|
| ISIN | GB00BF5G6K95 | Currency | GBX |
| Type | Equity | Trading Segment | ASQ1 |
| Record Status | Active | Trading Status | Closed |
| Industry | Health Care | Sector | Biotechnology |
| EMS | 3,000 | Prev Close | 237.50 |
| Shares in Issue (m) | 31.80 | Market Cap (£m) | 75.54 |
| PE Ratio | -5.25 | Div per Share () | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -45.20 | EPS Growth (%) | 18.85 |
| PEG | -0.28 | DPS Growth (%) | n/a |
| ROCE | -73.36 | Net Gearing | -42.15 |
| Quick Ratio | 4.04 | Current Ratio | 4.04 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 09 Nov | Stifel | Buy | 237.50 | 13.00 | 13.00 | Reiterates |
| 29 Jun | N+1 Singer | Buy | 237.50 | - | - | Reiterates |
| 27 Apr | N+1 Singer | Buy | 237.50 | 9.00 | 9.00 | Reiterates |
| 04 Apr | Stifel | Buy | 237.50 | 15.00 | 15.00 | Reiterates |
| 04 Jan | N+1 Singer | Buy | 237.50 | 9.00 | 9.00 | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 18 Apr 2019 | Prof Sir Chris Evans | Buy | 10,000 @ 228.70p | £22,870.00 |
| 11 Apr 2019 | John Berriman | Buy | 80,000 @ 225.00p | £180,000.00 |
| 11 Apr 2019 | Simon Cartmell | Buy | 7,758 @ 225.55p | £17,498.17 |
| 11 Apr 2019 | Prof Sir Chris Evans | Buy | 4,500 @ 221.50p | £9,967.50 |
| 11 Apr 2019 | Dr Mike Owen | Buy | 4,237 @ 236.00p | £9,999.32 |
